Contains a GLP-1 receptor agonist used in weight management
If buttocks injections trigger consistent discomfort despite proper technique, shifting to the abdomen or thigh for 24 weeks allows tissue healing while maintaining therapeutic semaglutide dosing
This means you may still experience side effects for these five weeks until the last dose has cleared your system, although the side effects should gradually decline
Results with Naltrexone, the active ingredient in Vivitrol, in Conway, Batesville, and Cabot vary from person to person, but many patients notice reduced cravings within the first one to two weeks of starting treatment
Risk factors that may prompt additional consideration include: Active gastrointestinal symptoms (nausea, vomiting, abdominal pain) Recent dose increases or being in the dose-escalation phase Higher doses of semaglutide Known gastroparesis or other conditions affecting gastric emptying Obesity with GERD or hiatal hernia Based on the 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies, rather than automatic postponement
With a fully equipped surgical suite along with the latest in non-surgical procedures, the medical professionals at Seattle Plastic Surgery aim to help patients achieve their goals using a combination of medicine and aesthetics